Ad

Tag: Indian Council of Medical Research (ICMR)

Punjab Logs 59 More Death,Harmanpreet Also Test+Covid 19

(Delhi,Chd) Punjab Logs 59 More Death,Harmanpreet Kaur Also Test+Covid 19
The 271 new fatalities Pushed death toll to 162114
New Fatalities Includes
102 from Maharashtra,
59 Punjab,
20 from Chhattisgarh,
16 from Karnataka,
14 from Tamil Nadu and
11 from Kerala.
India’s COVID-19 tally climbed to 1,20,95,855 with 56,211 more people testing positive for the infection in a span of 24 hours, while 271 more fatalities pushed death toll to 1,62,114, according to the Union Health Ministry’s data updated on Tuesday.
Registering a steady increase for the 20th day in row, active cases have increased to 5,40,720 comprising 4.47 per cent of the total infections, while the recovery rate has further dropped to 94.19 per cent.
According to the Indian Council of Medical Research (ICMR), 24,26,50,025 samples have been tested up to March 29 with 7,85,864 samples being tested on Sunday.
A total of 1,62,114 deaths have been reported so far in the country, including 54,283 from Maharashtra,
12, 684 from Tamil Nadu, 12,520 from Karnataka, 11,012 from Delhi, 10,325 from West Bengal,
8,790 from Uttar Pradesh and
7,210 from Andhra Pradesh and
6,749 from Punjab.
The Health Ministry stressed that more than 70 per cent of the deaths
occurred due to comorbidities.
Indian women’s T20 team captain Harmanpreet Kaur has tested positive for COVID-19 and is experiencing mild symptoms.

India Pushes Recovery Rate to 94.37% :Covid 19

(New Delhi)India Pushes Recovery Rate to 94.37%
The number of people who have recuperated from the disease surged to 91,00,792 pushing the national recovery rate to 94.37 per cent, while the COVID-19 case fatality rate stands at 1.45 per cent.
India’s COVID-19 caseload rose to 96.44 lakh, while the total number of people who have recuperated from the disease crossed 91 lakh pushing the national recovery rate to 94.37 per cent, according to the Union Health Ministry data updated on Sunday.
The COVID-19 active caseload plunged to almost 4 lakh after 138 days.
The total coronavirus cases mounted to 96,44,222 with 36,011 new infections being reported in a day, while the death toll crossed to 1.40 lakh with 482 new fatalities, the data updated at 8 am showed.
There are 4,03,248 active coronavirus infections in the country which comprises 4.18 per cent of the total caseload, the data stated.
India’s COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23 and 40 lakh on September 5. It went past 50 lakh on September 16, 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, and surpassed 90 lakh on November 20.
According to the ICMR, 14,69,86,575 samples have been tested up to December 5 with 11,01,063 samples being tested on Saturday.

अनिलविज कोवैक्सिन का परीक्षण टीका लगने के दो सप्ताह पश्चात संक्रमित हुए

(चंडीगढ़, हरियाणा )अनिलविज कोवैक्सिन का परीक्षण टीका लगने के दो सप्ताह पश्चात संक्रमित हुए
हरियाणा के स्वास्थ्य मंत्री अनिल विज कोरोना वायरस से संक्रमित पाए गए हैं। उन्होंने पिछले महीने परीक्षण के तौर पर कोरोना वायरस के खिलाफ विकसित किए जा रहे स्वदेशी कोवैक्सिन का टीका लिया था।
विज ने ट्वीट करके शनिवार को संक्रमित होने की जानकारी दी। उन्होंने एक ट्वीट के माध्यम से जानकारी देते हुए अपील की है कि हाल में उनके संपर्क में जो लोग आए हैं, वे जांच करा लें।
जननायक जनता पार्टी (जेजेपी) के तीन सदस्यों वाले एक प्रतिनिधि मंडल ने विज से शुक्रवार को मुलाकात की थी और कृषि कानूनों के खिलाफ ‘दिल्ली चलो’ मार्च में शामिल होने वाले किसानों के खिलाफ दर्ज मामलों को वापस लेने की अपील की थी। जेजेपी राज्य में भाजपा की सहयोगी पार्टी है।
विज ने कोविड-19 के खिलाफ संभावित टीके कोवैक्सिन के तीसरे चरण के परीक्षण में पहला स्वयंसेवी बनने की पेशकश की थी और उन्हें 20 नवंबर को इसकी खुराक अम्बाला कैंट के सिविल अस्पताल में दी गई थी।
कोवैक्सिन स्वदेशी टीका है और भारतीय आयुर्विज्ञान अनुसंधान परिषद (आईसीएमआर) के साथ मिलकर भारत बायोटेक इसे विकसित कर रही है।

Export of Anti-Malarial Drug Hydroxycloroquine BANNED

(New Delhi) Export of Anti-Malarial Drug Hydroxycloroquine BANNED
Indian government on Wednesday banned export of anti-malarial drug hydroxycloroquine, with immediate effect to ensure sufficient availability of the medicine in the domestic market.
Indian Council of Medical Research (ICMR) Director General Balram Bhargava had on Monday recommended the use of hydroxychloroquine for treating healthcare workers handling suspected or confirmed coronavirus cases and also the asymptomatic household contacts of the lab-confirmed cases.
The treatment protocol recommended by the ICMR-constituted National Task Force for COVID-19 has been approved by the Drug Controller General of India (DGCI) for restricted use in emergency situations.
In a notification issued on Wednesday, the Directorate General of Foreign Trade (DGFT), an arm of the commerce ministry which deals with export and import-related matters, said, ” government will allow export of the medicine on humanitarian grounds on case-to-case basis on the Ministry of External Affairs’ recommendation.”
According to some reports, demand for hydroxychloroquine and chloroquine, a related compound, have jumped after US President Donald Trump said that these salts were effective in treating COVID-19. People are panic buying this medicine.